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The development of glomerulosclerosis was studied
in murine chronic graft-versus-host disease (GvHD),
which is a model for human systemic lupus erythe-
matosus. The authors investigated the distribution
patterns of six components of the extracellular ma-
trix (ECM), ie., laminin, fibronectin, collagen typesI,
III, IV, and VI during the course of the disease. All of
these ECM components except collagen type I were
found in the glomeruli of normal mice, where all of
them were intrinsic constituents of the mesangium.
Laminin, fibronectin, and collagen type IV were also
found in the glomerular capillary walls. Starting 6
weeks after the induction ofGvHD and continuing at
week 8, the onset of an expansion of the mesangial
matrix was observed At the same time, the amounts
of laminin, fibronectin, and collagen typesIV and VI
increased Ten weeks after the onset of the disease,
glomerulosclerosis developed. Traces of the intersti-
tial collagen typef werefound in sclerotic glomeruli
The levels offourECM components, i.e., collagens III,
IV, VI, and laminin were markedly decreased in the
sclerotic glomeruli as compared with week 8. In con-
trast, the amount offibronectin in the sclerotic glo-
meruli increased dramatically. Immunoelectron mi-
croscopic examination showed fibronectin in the
sclerotic lesions, in contrast to laminin, collagen
type I, and collagen type IV It is concluded that the
sclerotic lesions in murine chronic GvHD contain
fibronectin The small amounts of the ECM compo-
nents laminin, as well as collagens III, IV, and VI in
the sclerotic glomeruli in GvHD, might represent
remnants of mesangial material and collapsed cap-
illary walls These components areprobably replaced
by increasedproduction and/or accumulation ofcol-
lagen type I and fibronectin.
140:1147-1156)
(Am J Pathol 1992,
Progressive glomerular sclerosis is a severe complica-
tion of many forms of renal disease. In the course of this
process, structures in the glomerulus are replaced by
fibroblasts and matrix.1 This in turn leads to impairment of
the filtration function of the kidney. Not much is known
about the underlying mechanisms. Hemodynamic and
genetic factors may play a role.2'3 Interleukin 1 and trans-
forming growth factor-p are known to stimulate extracel-
lular matrix (ECM) production by glomerular cells and
have been postulated to play a central role in the patho-
genesis of glomerulosclerosis.4 A better understanding
of the development of glomerulosclerosis will improve di-
agnosis and treatment in patients. Research in this field
has focused on experimental models.
Murine graft-versus-host disease (GvHD) can be
used as a model for systemic lupus erythematosus in
humans.7 GvHD is induced by transfer of DBA/2 lympho-
cytes into (C57BU1 O*DBA/2)F1 hybrids. This leads to an
alloimmune reaction of parental T lymphocytes activated
by H-2-incompatible structures of the recipient mice.8'9
According to Via and Shearer,10 the disease is the result
of a deficient cytotoxic T-cell response in the DBAI2-
derived inoculate. This leads to uncontrolled proliferation
of autoantibody-producing B cells in the host.11 The re-
sult is an SLE-like syndrome in which severe immune-
complex glomerulonephritis (ICGN) is one of the major
symptoms. In this model, ICGN is characterized by de-
position of autoantibodies in the mesangium and along
the GBM, resulting in thickening of the GBM, the forma-
tion of spikes and expansion of the mesangial matrix.
From week 10 on, the development of glomerulosclerosis
can be observed by light microscopic examination and
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leads to severe renal failure and finally to the death of the
animal.
Molecular dissection of the ECM in humans and lab-
oratory animals, suggested that the sclerotic process is
characterized by an abnormal production of ECM com-
ponents.'2-14 To obtain more insight into the pathogen-
esis of glomerulosclerosis in our model of experimental
lupus nephritis, we successively investigated the depo-
sition patterns of the ECM components laminin, fibronec-
tin, and collagen types 1, 111, IV, and VI. For this purpose,
we used the techniques of immunofluorescence, immu-
noelectron microscopic examination, and the recently
developed technique of reflection-contrast microscopy
with peroxidase staining. This new technique provides
enhanced detection sensitivity in immunostaining15 and




C57BU10 (H-2b/b) and DBA/2 (H-2d/d) mice were pur-
chased from Olac 1976 Ltd. (Bicester, Oxfordshire OX6
OTP, UK). (C57BU1 0*DBA/2)F1 hybrid mice were bred
in our animal facilities. Female DBA/2 mice aged 7 to 8
weeks served as donors. Female Fl hybrids aged 8 to 10
weeks served as recipients. For the present study, we
used 25 experimental Fl mice and 5 age- and sex-
matched control mice.
Induction of GvHD
Spleens, lymph-nodes (mesenteric, cervical, and in-
guinal), and thymi from DBA/2 donors were removed un-
der aseptic conditions. Single-cell suspensions were pre-
pared by mincing the tissue in sterile RPMI 1640 and
gently pressing the fragments through a steel sieve (150
,um pore diameter). The suspensions were filtered
through a nylon sieve (71 ,um pore diameter), after which
the cells were passed through a sterile Pasteur pipette
loosely packed with cotten wool. The suspensions were
washed twice in RPMI 1640 medium and centrifuged for
10 minutes at 250g. The pellets were resuspended in
RPMI 1640. The total number of cells and the proportion
of vital cells were determined by Trypan blue exclusion
and phase-contrast microscopic examination. The sus-
pensions were washed again, and the pellets were re-
suspended in Hanks' balanced salt solution (HBSS). The
suspensions were mixed. On days 0, 3, 7, and 10, the Fl
recipients were injected intravenously with 50*106 viable
DBA/2 cells in 0.25 ml HBSS. The dose was composed of
approximately 60% spleen cells, 30% thymocytes, and
10% lymph-node cells. Control mice were injected simul-
taneously with 0.25 ml phosphate-buffered saline (PBS).
Follow-up of Fl Mice
The albumin content of the urine of the GvHD Fl and
control mice was determined 1 week before and 2 weeks
after the first injection of parental cells and then at two-
weekly intervals. The animals had been kept in urine-
collection cages for 18 hours with free access to water
and food. The albumin level was assessed by rocket
electrophoresis against rabbit anti-mouse albumin, which
had been produced by immunization of a rabbit with pu-
rified mouse serum albumin (Sigma Chemical Corpora-
tion, St. Louis, MO). This mouse albumin was also used
as standard.16 After urine collection, the mice were anes-
thetized with diethylether and blood was collected from
the orbital plexus. Serum samples were prepared and
tested to detect the presence of autoantibodies.9 The
direct Coomb's test was used to assess the in vivo fixa-
tion of immunoglobulins by erythrocytes.9 Groups of five
mice each were killed every other week starting at week
4 and ending at week 12. After perfusion with Dulbecco's
phosphate-buffered saline (PBS), the kidneys were re-
moved. Small pieces of kidney tissue were embedded in
Lowicryl for electron and reflection microscopic examina-
tion. Some of the tissue was fixed in 10% buffered forma-
lin, dehydrated, and then embedded in Paraplasts (Am-
stelstad, Amsterdam, The Netherlands) for light micro-
scopic examination. The remaining kidney tissue was
frozen in CO2 ice-cooled isopentane and stored at
- 70°C until use for the immunofluorescence studies. For
electron and reflection microscopic examination, the kid-
neys were perfusion-fixed with paraformaldehyde and
0.25% glutaraldehyde in 0.1 mol/I PBS, and embedded
in Lowicryl.
Antibodies
We used rabbit-anti-mouse IgG obtained from Janssen
(Olen, Belgium), affinity-purified goat-anti-type 1, anti-type
111, and anti-type IV collagen antisera from Sera-lab (Sus-
sex, England), rabbit-anti-EHS laminin from E-Y laborato-
ries (San Mateo, CA), polyvalent rabbit serum against
type VI collagen from Heyl (Berlin, Germany), and poly-
clonal antiserum to human fibronectin from Sigma (St
Louis, MO). As second antibodies in the immunofluores-
cence studies, we used FITC-labeled goat-anti-rabbit
IgG and rabbit-anti-goat IgG from Nordic (Tilburg, The
Netherlands). For reflection contrast microscopic exami-
nation, we used peroxidase-labeled swine anti-rabbit
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and peroxidase-labeled swine anti-goat antibodies
(DAKO, Denmark) and gold-labeled goat-anti-rabbit-
G15 as second-step antibodies (Amersham). In the im-
munoelectron microscopic studies, rabbit-anti-goat IgG
was used as second antibody. Gold-labeled goat-anti-
rabbit-G15 was used as third antibody, and as second
antibody in laminin staining. Specificities were deter-
mined using indirect and direct ELISA, indirect immuno-
fluorescent staining, indirect immunocytochemical anal-
ysis, and dot blotting techniques.
Histologic Techniques
The kidney tissue was processed for light microscopic
and immunofluorescence studies as described else-
where.17 The light-microscopic slides were stained with
periodic acid-Schiff (PAS) or hematoxylin-eosin (H&E).
The immunofluorescence slides were scored double-
blind by two observers independently of each other. Im-
munoelectron microscopic examination was completed
according to Abrahamson et al.18 On the grids the sec-
tions were poststained with uranyl acetate and Reynold's
lead citrate, and examined in a Philips CM10 electron
microscope, operating at 60 kV. Reflection-contrast mi-
croscopic examination and postembedding histochemi-
cal analysis were done according to Cornelese-ten Velde
et al15 with a few modifications. Briefly, the kidneys were
perfusion-fixed with 1% paraformaldehyde and 0.25%
glutaraldehyde in 0.1 mol/l PBS (pH 7.4). Dehydration
and embedding were performed according to Altman et
al.19 Ultrathin sections (±80 nm) were caught on ami-
nocylane-coated slides. The slides were then preincu-
bated in 1% bovine serum albumin (BSA) in PBS, and
reincubated overnight at 40C with the first antibody. The
second antibody was incubated for 2 hours. When a per-
oxidase-labeled second antibody had been used, the
sections Were incubated 10 minutes in a solution of 50
mg/i 00 ml diaminobenzidine and 0.01% hydrogen per-
oxide in 0.05 mol/I TRIS-HCI (pH 7.6). The slides were
washed in PBS and in double-distilled water, before be-
ing examined. The slides were not counterstained or cov-
ered with a coverslip.
Results
Development of GvHD
The albumin excretion of the diseased animals rose
sharply and reached the highest levels in week 12
(30,000 ± 2,140 ,ug/18 hr vs 40 ± 2 ,ug/18 hr for the
control mice). Ascites and edema developed in the ma-
jority of the treated animals. Antinuclear antibodies devel-
oped in all treated animals. In the course of the disease,
92% of the animal sera became positive in the direct
Coomb's test, indicating the development of autoimmu-
nity. Light and electron microscopic examinations
showed a lupus type of nephritis with glomerular prolifer-
ation as well as membranous nephritis, complicated by
glomerular sclerosis starting 10 weeks after the induction
of GvHD. At this stage, Bowman's capsule was markedly
thickened, especially at the hilus. Furthermore adhesions
were seen between the visceral and parietal glomerular
epithelia.
The glomerular deposition patterns of the ECM mole-
cules were determined semiquantitatively by immunoflu-
orescence techniques. The results are summarized in
Table 1. We also studied the localization patterns of lam-
inin, fibronectin, collagen type 1, and type IV, and the IgG
deposits at the ultrastructural level, using reflection-
contrast and immunoelectron microscopic examinations.
Four sequential ultrathin sections of material representing
GvHD week 10 material were cut, immediately followed
by a section with a thickness of 0.5 n.m. The ultrathin
slides were stained with antibodies against IgG, laminin,
collagen IV, and fibronectin. The thicker section was
given a PAS-staining. The results are shown in Figure 2.
On this basis conclusions could be drawn concerning
the distribution of these ECM components in relation to
the IgG-containing deposits and the sclerotic lesions. The
signals of the other ECM components studied were too
weak for detection by these methods.
IgG Deposits
The immunofluorescence and reflection-contrast micro-
scopic studies showed IgG in a mainly linear pattern
along the glomerular capillary wall, starting 2 weeks after
the induction of GvHD. The distribution of IgG changed to
a more granular pattern after 6 to 8 weeks. At this stage,
the kidneys of diseased animals showed electron-dense
deposits in the mesangium and subepithelially along the
glomerular capillary wall at the ultrastructural level. Incu-
bation with anti-IgG antibodies led to staining of the elec-
tron-dense deposits (Figure 1). The GBM showed irreg-
ular thickening with formation of spikes. With the devel-
opment of glomerular sclerosis, the presence of IgG at
the sites of the sclerotic lesions decreased (Figure 2b).
Immunoelectron microscopic examination showed few
deposits of IgG in the sclerotic lesions as compared with
the presence of IgG in the electron-dense deposits in the
remnants of the mesangial matrix and GBM (Figure 3a).
Laminin was localized in the mesangium and the glo-
merular capillary wall in normal mice (Figure 2e). Six
weeks after the induction of GvHD, the amount of laminin
in the mesangium as well as that in the glomerular cap-
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Table 1. Deposition ofExtracellular Matrix Molecules in Kidneys ofMice Sufferingfrom GvHD, as Determined
Semiquantitatively by Immunofluorescence Studies
lam col col IlIl col IV col VI fn
nFl mes ++ - + ++ + ++
GCW + + +
BC + + + ++ + +
TBM + + + + + + + +
int + + ++ +
wk4 mes ++ - + ++ + ++
GCW + - _ + _ +
BC + + + + + + +
TBM + + + + + + + +
int + + ++ - - +
wk6 mes +++- + +++ +/++ +++
GCW +/+ + + ++
BC ++ ± + ++ + +
TBM + + + + + + +
int + ++ + - +
wk8 mes +++- + +++ +/++ +++
GCW +/++ _ ++
BC ++ + + ++ + +
TBM + + - + + + + +
int + ++ + - +
wk 10/12 gsl - - - - -+ + + +
mes + + + + + + + +
GCW +/++ +
_ ++
BC + + + + ++
TBM + + + + + + + + +
int + + ++ +
mes = mesangium, GCW = glomerular capillary wall, BC = Bowman's capsule, TBM = tubular basement membrane, int = interstitium,
gsl = glomerular sclerotic lesion, lam = laminin, col = collagen type 1, fn = fibronectin.
illary wall increased (Figure 2f). Two weeks later, the lo-
calization of laminin had not changed. At week 10, how-
ever, the distribution of laminin changed radically at the
sites where glomerulosclerosis developed. In the mesan-
gial areas that were not yet sclerotic, the laminin distribu-
tion was the same as at week 8. However, in the sclerotic
regions the presence of laminin was dramatically de-
creased relative to the occurrence at week 8 (Figure 2g).
Immunoelectron microscopic examination at weeks 6
and 8 showed laminin around the deposits, and concen-
trated mainly at the top of the spikes (Figure 3b). In scle-
rotic glomeruli at week 10, laminin was found in mesan-
gial and capillary material around the sclerotic lesions
(Figure 3c).
Collagen was found in small amounts in the intersti-
tium, the tubular basement membrane (TBM), Bowman's
IS i.i.:-r fi> AI. !t
Figure 1. Electronmicrograph of the glomerular basement membrane of a mouse 8 weeks after induction of GvHD. The electron-dense
deposits react with anti-IgG antibodies (x23000). US = urinay space; CL = capillwy lumen.
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capsule, and more abundantly in vessel walls, but not in
the glomerular capillary network of normal Fl mice. Up to
8 weeks after the onset of the disease, a slight increase in
the interstitium, the TBM, and Bowman's capsule oc-
curred. Starting at week 10, traces of collagen were
seen in the glomeruli. At that time there was a dramatic
increase of this type of collagen in the interstitium, the
TBM, and Bowman's capsule (Figure 4). Immunoelectron
microscopic examination at week 10 showed small
amounts of collagen type in the mesangial matrix, but
not in the glomerular sclerotic lesions (Figure 3d).
Collagen III was found in the mesangium of glomeruli
of normal mice. There was no staining of the glomerular
capillary wall. In the course of the disease, staining of the
mesangium showed no to a slight increase. Sclerotic glo-
meruli at week 10 showed a decrease of collagen Ill (Fig-
ure 5). The sclerotic regions did not stain for collagen
type 111. Compared with normal glomeruli, the amount of
collagen Ill increased, especially interstitially, after GvHD
induction.
Collagen IV was present in the mesangium and the
glomerular capillary wall of normal mice. Bowman's cap-
sule was also strongly positive for collagen type IV. Start-
ing at week 6 the amount of collagen IV in the mesangium
increased. At weeks 10 and 12, in the sclerotic lesions,
the amount of collagen type IV was smaller that it had
been in week 8. Parts of the glomeruli that had not yet
become sclerotic, showed a distribution pattern similar to
that seen in week 8 (Figure 2c).
Immunoelectron microscopic examination showed
collagen type IV in the mesangial matrix and in the glo-
merular capillary wall around the electron-dense depos-
its at week 6 and 8. In sclerotic glomeruli, collagen type IV
was present in the mesangial matrix and the remainders
of the GBM, but not in the sclerotic lesions (Figure 3e).
Collagen VI was found in the mesangium, Bowman's
capsule, the TBM, and around the vessel walls in normal
mice. Six weeks after the induction of the disease, expan-
sion of the mesangium began and an increase of colla-
gen type VI occurred. At weeks 10 and 12, a marked
increase had occurred in the interstitium, especially
around the vessel walls. In the glomeruli, collagen VI had
almost totally disappeared. Nonsclerotic parts of glomer-
uli showed mesangial staining resembling that seen at
week 8 (Figure 6).
Fibronectin was found both in the mesangium and the
glomerular capillary wall of control mice. Bowman's cap-
sule and the TBM were positive. Six weeks after the onset
of GvHD, fibronectin increased in the mesangium, but
remained unchanged in the capillary wall. This picture
persisted in week 8. The sclerotic glomeruli appearing at
week 10 showed a large amount of fibronectin (Figure
2d).
Immunoelectron microscopic examination showed a
diffuse distribution of fibronectin in the sclerotic lesions.
Within the lesions, differences in the degree of electron
density occurred. The more electron-dense material in
the sclerotic lesions stained more intensely for fibronectin
than the less electron-dense parts did. Fibronectin was
also present in the mesangial matrix and in the remnants
of GBM around the sclerotic lesions (Figure 3f).
Discussion
In the present study, we investigated glomerular sclerosis
as a complication of immunologically mediated glomer-
ulonephritis. Improvement of the diagnosis and treatment
of patients requires a better understanding of the mech-
anisms underlying the development of glomerulosclero-
sis. To this end, we studied the distribution patterns of a
number of extracellular matrix components, i.e., laminin,
fibronectin, and collagen types 1, 111, IV, and VI in the
experimental murine GvHD model, making use of immu-
nofluorescence, immunoelectron microscopy, and the
recently developed technique of reflection-contrast mi-
croscopy with peroxidase staining. The reflection-
contrast microscopic technique offers a useful supple-
ment to the well-known technique of immunofluores-
cence. The detection level of the former method is slightly
lower, because less antigen is present in the ultrathin
sections.15 However, the staining is much more precise.
The minimal thickness of these sections makes it possi-
ble to define a sequential range of serial sections through
a single glomerulus. The morphology shown by these
ultrathin sections is comparable, which means that the
distribution patterns of the various ECM components can
be compared in relation to each other and to immuno-
globulins present.
In normal (C57BL110*DBA/2)F1 hybrid mice, we
found the components laminin, fibronectin, collagen
types 111, IV, and VI, in the glomerular mesangium. Lam-
inin, fibronectin, and in small amounts, collagen type IV,
were also found in the glomerular capillary wall.
The finding of collagen type III in the glomeruli of nor-
mal mice is in itself remarkable. Most other authors did
not find collagen type III in normal glomeruli of hu-
mans122021 or rats 13,22,23 On the other hand, Downer et
al24 reported finding trace amounts of interstitial collagen
in some glomeruli of control New Zealand White rabbits.
Thus, differences in collagen Ill distribution might exist
between species or even between strains.
The amounts of all the ECM components studied in-
creased during the course of the disease. Changes be-
gan to occur 6 weeks after the induction of GVHD. At this
stage, the mesangium started to expand. Irregular thick-
ening of the GBM and the formation of spikes were also
observed. IgG-containing electron-dense deposits were
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Figure 2. a: Glomerulus 10 weeks after the induction of GvHD, stained according to the PAS technique. b: IgG distribution in glomerulus
at week 10. c: Collagen type IVat week 10. d: Fibronectin at week 10. e: Laminin distribution in a glomerulus ofa normal Fl hybrid mouse.
f: Laminin distribution 6 weeks after induction ofGvHD. g: Laminin distribution at week 10; (a-d) and (g) show sequential sections ofone
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Figure 3. Immunoelectron micrographs of (a) IgG distribution in a glomerulus 10 weeks after the induction ofGvHD, arrows indicate IgG
containing electron-dense deposits; (b) glomerular basement membrane showing localization oflaminin at week 8; (c) Laminin ditribution
at week 10; (d) collagen I (arrows) at week 10; (e) collagen IVat week 10; and (f) fibronectin at week 10. Magnification a, c-f, x 7000;
b, X28000. GSL = glomerular sclerotic lesion, MM = mesangial matrix, CL = capillary lumen.
1154 Bergijk et al
AJP May 1992, Vol. 140, No. 5
Figure 4. Immunofluorescence micrograph
showing the distibution pattern of collagen
typeI 10 weeks after GvHD induction (x630).
Starting 10 weeks after induction of the disease, glo-
merular sclerosis developed. This was associated with
adhesion to and thickening of Bowman's capsule. The
first striking finding was the appearance of traces of the
interstitial collagen type in the glomerulus at this time-
point. Our finding is in agreement with the observations
made by Foellmer et al,16 who suggested an association
between the presence of collagen and interruption of
Bowman's capsule in rats with anti-GBM nephritis. A ge-
notype switch of glomerular cells leading to local produc-
tion of collagen type has also been suggested as an
explanation for the presence of interstitial collagens in a
glomerulus.25 Our finding of collagen type in the mes-
angial matrix and not in the glomerular sclerotic lesions
might be in agreement with this hypothesis. In addition,
diminished collagenase activity in sclerotic glomeruli
cannot be ruled out as an explanation for the presence of
collagen type in sclerotic glomeruli. This could be due to
damage of the cells producing this enzyme.
Second, we found striking differences between the
distribution patterns of the ECM components in the scle-
rotic glomeruli. Fibronectin was present in the sclerotic
lesions. The other components we investigated showed
a sudden decrease relative to the level at week 8. We had
the impression that these components were replaced by
the sclerotic lesions. The traces of ECM components
found around the lesions are believed to have been rem-
nants of mesangial material and/or of collapsed capillary
walls. The finding of differences in the occurrence of in-
dividual ECM molecules in sclerotic glomeruli is in itself
interesting. Recently, Ikeda et al26 found differences in
the localization of various ECM components in diabetic
glomerular lesions. They found that collagen IV occurred
in the core portion of the nodular lesion, whereas colla-
gen VI was seen in the surrounding laminated acellular
area. These authors believed that the formation of the
lesions in diabetic microaneurysms might be based on
the increase of type VI collagen.
Figure 5. Immunofluorescence micrograph
showing the distibution pattern of collagen
type III 10 weeks after GvHD induction
,, , ~~~(X630).
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Figure 6. Distrbution of type VI collagen in
a sclerotic glomerulu-s 12 weeks after the in-
pK~~~T.~~duction of GvHD. Tyvpe W7 collagen had al-disappeared in the sclerotic areas (ar-
rowheads). Immunofluorescence micrograph(x630).
Last year, Funabiki et al27 reported fluorescence stud-
ies in patients with glomerulonephritis and diabetic ne-
phropathy. In the advanced stages of glomerulonephritis,
they found a marked increase of types IV and VI colla-
gen, laminin, and fibronectin in the mesangium. The dis-
tribution extended along the glomerular capillary walls as
well. During the progression of glomerulosclerosis, they
found a significant decrease in the amount of type IV
collagen, laminin, and fibronectin, whereas the occur-
rence of interstitial collagen types and Ill was observed
focally in the glomerular lesions.
The observed influx of collagen type and the de-
creased amounts of laminin and collagen IV in our model
in the sclerotic stage is comparable with Funabiki's find-
ings in the aforementioned renal diseases. Markedly di-
vergent, however, is our finding of fibronectin in the scle-
rotic lesions. Unfortunately, our model does not allow in-
vestigation of the composition of sclerotic lesions during
the progression of glomerulosclerosis, because the mice
do not live long enough.
The glomerular sclerotic lesions appeared to consist
of material of variable electron density in immunoelectron
microscopic examination as well as in routine electron
microscopic examination. The more electron-dense parts
of the lesions contained more fibronectin than the less
electron-dense parts did. The sclerotic lesions in GvHD
probably contain a variety of molecules. Albumin, trans-
ferrin, and fatty acids were not among them (unpublished
results).
There are two possible explanations for the increased
presence of fibronectin in the glomeruli of GvHD mice.
First, there might be an accelerated increase of the syn-
thesis and excretion of fibronectin or decreased break-
down during the development of glomerulosclerosis. The
second hypothesis is that there is an accumulation of
exogenous fibronectin from the circulation. During the
course of GvHD, a dramatic change in glomerular mor-
phology was seen, including thickening of the glomerular
capillary walls and narrowing of the capillary loops. This
might lead to trapping of exogenous fibronectin and other
components from the circulation into the glomerulus. The
other ECM components might be pushed aside or cov-
ered by the accumulated material. The accumulation of
fibronectin in the sclerotic lesions might be facilitated by
fibronectin-binding receptors. Recently, a pilot study
showed increased expression of adhesion molecules of
the integrin family. Furthermore histologic staining for al-
bumin, transferrin, and fatty acids showed that the devel-
opment of glomerulosclerosis in murine chronic GvHD is
not a process of nonspecific trapping of proteins from the
circulation. However, it is accompanied by bloodclotting
as shown by fibrin and fibrinogen staining (unpublished
results).
Further investigations, including mRNA studies, are
needed to establish which mechanisms underlie the de-
velopment of glomerulosclerosis in murine chronic GvHD
and the abnormal composition of the ECM in these le-
sions. We recently speculated about the nature of pro-
gression in experimental lupus nephritis.28 Investigations
in this field can contribute to a better understanding of the
development of glomerulosclerosis, and thus to improve-
ment of the diagnosis and treatment of patients with glo-
merulonephritis.
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